Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort
| Autor: | Juraj Duras, Roman Hájek, Michal Kaščák, Hana Plonkova, Katerina Benkova, Zdenek Koristek, Tereza Popkova, Michal Simicek, Lucie Cerna, Tomas Jelinek, Jana Mihalyova |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Oncology
Male Cancer Research medicine.medical_specialty Dexamethasone Translocation Genetic Bortezomib chemistry.chemical_compound Internal medicine Antineoplastic Combined Chemotherapy Protocols Medicine Humans Stage (cooking) Multiple myeloma Aged Retrospective Studies Aged 80 and over Chromosomes Human Pair 14 Sulfonamides business.industry Venetoclax Chromosomes Human Pair 11 Hematology General Medicine Middle Aged medicine.disease Bridged Bicyclo Compounds Heterocyclic Prognosis Survival Rate chemistry Cohort Female business Multiple Myeloma medicine.drug Follow-Up Studies |
| Zdroj: | Hematological oncology. 38(3) |
| ISSN: | 1099-1069 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text